More than 38 million people in the U.S. are living with diabetes.

Health insurance companies, including CVS Caremark, are altering coverage for GLP-1 weight loss medications like Zepbound, ...

The country’s Medicines and Healthcare products Regulatory Agency’s (MHRA) Yellow Card scheme, the UK’s official system for ...

Obesity is a common risk factor for several serious health conditions like diabetes, heart disease, hypertension, fatty liver ...

Do those on Zepbound have to switch to Wegovy after Caremark drops Zepbound from preferred coverage? What options are there?

Business Insider spoke to Eli Lilly's new president of cardiometabolic health, who shared the company's aggressive incretin ...

Popular weight loss drugs like Ozempic and Mounjaro are now linked to rare but serious cases of acute pancreatitis, including ...

The two largest health insurers in Massachusetts are effectively telling the drug companies that they may seek a rapidly ...

Sales of Eli Lilly’s Mounjaro double in a month; Novo Nordisk’s Wegovy enters market amid rising obesity and diabetes rates.

Insurers are cutting coverage, citing costs. But there’s seldom any discussion of the return on investment from these drugs ...

The drug is now available for prescription in New Zealand but there are clouds to go along with the silver linings - such as ...

Weight-loss jabs will be made available to the poorest who have the highest need, the Government has said in the NHS 10-year ...